Cunning Capital Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Cunning Capital Partners's AMGN Position: Q4 2024 in Review
Cunning Capital Partners sold out of Amgen (AMGN) in Q4 2024, closing a stake of 5,455 shares — an estimated $1.76M sold.
Cunning Capital Partners first reported a position in AMGN in Q4 2022 and held it in 7 quarters. The position peaked at $1.76M in Q3 2024. 2,856 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.
- Cunning Capital Partners reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
- Cunning Capital Partners sold 5,455 Amgen shares in Q4 2024, an estimated $1.76M.
- Cunning Capital Partners first reported a position in Amgen in Q4 2022 and held it in 7 quarters.
- Cunning Capital Partners's Amgen position peaked at $1.76M in Q3 2024.
- 2,856 funds tracked by Wall St. Rank held Amgen as of Q4 2024.
Based on Cunning Capital Partners's 13F filing for Q4 2024, filed 13 Feb 2025.